Economic pressures push IC device prices down as firms offer discounts
This article was originally published in Clinica
The price being paid by publicly funded health services for devices used in interventional cardiology (IC) in the EU is going down. According to a report by the Millenium Research Group, IC device vendors are engaging in price undercutting and “ offering high-volume discounts or bundling deals with other products in their portfolios in order to encourage sales, resulting in price erosion”. Hospital purchasers are having to operate within set devices, and often forced to choose lower-cost devices. One solution to this is bulk purchasing where products are offered at lower cost, adding to price erosion. The practice of manufacturers offering high-volume sales for products at significant discounts is becoming more common across Europe, particularly in the Nordic countries and Spain.
You may also be interested in...
Those marketing products covered under the EU’s MDR and IVD Regulations have plenty of reading this month to help them prepare. More details have also emerged about the UK’s regulatory future.
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.